ArticleThe Journal of urology2014

Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.

Hiten D Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.